STING1 and rhabdomyosarcoma: In comparison, combination therapy with repeated administration of STING agonist was necessary for TLS development in rhabdomyosarcomas, suggesting the importance of STING activation for TLS induction in ‘immune cold’ tumors (Fig. 2c).